Finzati - Logo
RPTX logo

Repare Therapeutics Inc.

RPTX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2025
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$114.24M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 330.9%Manageable debt level · 0.01Healthy liquidity · 6.77Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 14, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$114.24M
52W Range0.89 - 2.66
Beta0.96
Gross Margin74.98%
Oper. Margin-174.88%
Profit Margin-158.37%
Debt/Eq0.01
Current Ratio6.77
Quick Ratio6.77
Target$16.00

Investment DNA

How strong this company looks for long-term investors

57
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 330.9%Manageable debt level · 0.01Healthy liquidity · 6.77Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-06
Low
$3.00
Mean
$16.00
Median
$15.00
High
$30.00

Company Overview

IPO: 6/19/2020
Industry: Biotechnology
P/B i: 0.37
Debt / Equity i: 0.01
Operating Margin: -174.88%
Net Margin: -158.37%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 6.77
Quick Ratio: 6.77
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
BVF PARTNERS L P/IL
Transaction: 01/28/2026
SELL
Change
-548,938
Price
$2.20
Filing
01/30/2026
Type
SELL
Alves Sandra Isabelle Barros
Transaction: 01/28/2026
SELL
Change
-31,622
Price
$2.20
Filing
01/28/2026
Type
SELL
Alves Sandra Isabelle Barros
Transaction: 01/28/2026
SELL
Change
-24,500
Price
$1.07
Filing
01/28/2026
Type
SELL